Non-Invasive Prenatal Testing Market Share, Size, Trends and Forecasts 2016-2020
- Submitted by: Marketreport
- Views: 74
- Category: Other
- Date Submitted: 09/16/2016 12:59 AM
- Pages: 4
- Report this Essay
Technavio Announces the Publication of its Research Report Global Non-Invasive Prenatal Testing (NIPT) Market 2016-2020
Technavio recognizes the following companies as the key players in the global non-invasive prenatal testing (NIPT) market: BGI Genomics, Illumina, LifeCodexx, Natera, and Sequenom.
Other Prominent Vendors in the market are: Ariosa Diagnostics, Berry Genomics, CombiMatrix, F. Hoffmann-La Roche, Genpharm Services, Laboratory Corporation of America Holdings, LifeLabs Genetics, Quest Diagnostics, Safembryo, and Sengenics.
Browse full report with TOC@ https://marketreportscenter.com/reports/383375/global-non-invasive-prenatal-testing-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Increase in partnerships and collaborations will be a challenge for the market. Vendors enter into partnerships and collaborations to extend their product offerings, increase their market shares, and expand their operations. These partnerships and collaborations help vendors enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. For instance, in 2015, Human Longevity entered into a partnership with Roche Diagnostics to conduct whole-genome sequencing of Roche Diagnostics' subsidiary Genentech's de-identified samples. The partnership helped Roche Diagnostics analyze patient samples based on precise genetic categories and discover new diagnostics and targeted therapies. In 2011, Natera formed a partnership with DNA Diagnostics Center to enter the market. These partnerships and collaborative activities are accelerating drug discovery efforts, which will lead to the development of new therapies to detect chromosomal abnormalities in neonates.
According to the report, the number of neonates with chromosomal disorders is on the rise worldwide due to rapid urbanization, child-bearing at an advanced maternal age, pollution, and increased consumption of alcohol consumption. This factor will be a...
Technavio recognizes the following companies as the key players in the global non-invasive prenatal testing (NIPT) market: BGI Genomics, Illumina, LifeCodexx, Natera, and Sequenom.
Other Prominent Vendors in the market are: Ariosa Diagnostics, Berry Genomics, CombiMatrix, F. Hoffmann-La Roche, Genpharm Services, Laboratory Corporation of America Holdings, LifeLabs Genetics, Quest Diagnostics, Safembryo, and Sengenics.
Browse full report with TOC@ https://marketreportscenter.com/reports/383375/global-non-invasive-prenatal-testing-market-2016-2020
Commenting on the report, an analyst from Technavios team said: Increase in partnerships and collaborations will be a challenge for the market. Vendors enter into partnerships and collaborations to extend their product offerings, increase their market shares, and expand their operations. These partnerships and collaborations help vendors enhance their R&D capabilities for manufacturing innovative devices that meet consumer needs. For instance, in 2015, Human Longevity entered into a partnership with Roche Diagnostics to conduct whole-genome sequencing of Roche Diagnostics' subsidiary Genentech's de-identified samples. The partnership helped Roche Diagnostics analyze patient samples based on precise genetic categories and discover new diagnostics and targeted therapies. In 2011, Natera formed a partnership with DNA Diagnostics Center to enter the market. These partnerships and collaborative activities are accelerating drug discovery efforts, which will lead to the development of new therapies to detect chromosomal abnormalities in neonates.
According to the report, the number of neonates with chromosomal disorders is on the rise worldwide due to rapid urbanization, child-bearing at an advanced maternal age, pollution, and increased consumption of alcohol consumption. This factor will be a...